NCATS SBIR Phase I
Supports small businesses testing translational science tools and technologies through early feasibility and commercialization groundwork.
The National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health, administers SBIR Phase I grants (R43) to fund small US businesses seeking to establish the technical merit and feasibility of translational science innovations. NCATS focuses on four priority topic areas: preclinical drug discovery and development, biomedical and clinical and health …
Feasibility research for small businesses in NCATS priority areas: preclinical drug discovery, biomedical and health research informatics, clinical and implementation research, and rare disease.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline